MAPLE-UK
Recruiting
250 enrolled
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
Completed
14,000 enrolled
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Recruiting
10,000 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
CARES
Completed
744 enrolled
Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence
Phase NA Unknown
100 enrolled
RELIEF-1
Phase NA Terminated
2 enrolled
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Phase 2 Terminated
8 enrolled
Mast Cell Activation Test in Allergic Disease
Completed
19 enrolled 17 charts
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Phase 3 Unknown
330 enrolled
APOLO
Completed
152 enrolled
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Phase 1 Completed
32 enrolled
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
Phase 4 Completed
100 enrolled 8 charts
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Phase 2 Completed
147 enrolled 10 charts
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
Phase 4 Completed
81 enrolled 18 charts
CryoSpray Ablation(tm)Thoracic Patient Registry
Withdrawn
Gemini Symbicort pMDI
Phase 3 Completed
615 enrolled
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
Completed
1,182 enrolled
Study Evaluating Etanercept in Moderate to Severe Asthma
Phase 2 Completed
120 enrolled